Dynamic survival prediction using longitudinal AGR in unresectable locally advanced esophageal squamous cell carcinoma
Background Immune checkpoint inhibitor (ICI)-based induction therapy followed by definitive radiotherapy has emerged as a promising treatment strategy for patients with unresectable locally advanced esophageal squamous cell carcinoma (LA-ESCC). However, many patients still experience disease progression and poor clinic...